The effects of aztreonam on fecal flora and on descarboxy prothrombin (PIVKA-II) in plasma and γ-carboxyglutamic acid (Gla) in urine as an index of vitamin K metabolism were studied in seven children (age range, 2 months to 2 years) with urinary tract infections. Daily doses of aztreonam were 60 to 80 mg/kg. Stool specimens were obtained before the treatment, on days 3 to 5 of aztreonam use, and from 3 to 5 days after the cessation of treatment. The counts of enterobacteria decreased (P < 0.01) and those of streptococci increased (P < 0.05) during aztreonam treatment. The anaerobic organisms, especially bifidobacteria and bacteroides, showed no marked change. PIVKA-II and Gla were investigated before and during the treatment with aztreonam. PIVKA-II was not detected in seven patients before or during aztreonam use. There were no significant differences in the levels of Gla in urine before or during the treatment.
CITATION STYLE
Sakata, H., Kakehashi, H., Fujita, K., & Yoshioka, H. (1990). Effects of aztreonam on fecal flora and on vitamin K metabolism. Antimicrobial Agents and Chemotherapy, 34(6), 1045–1047. https://doi.org/10.1128/AAC.34.6.1045
Mendeley helps you to discover research relevant for your work.